Renue Blue™ Body Cream Shows Promising Results in Citruslabs Study
Renue Blue™ Body Cream Shows Promising Results in Citruslabs Study
PR Newswire
CALIFORNIA, United States, Sept. 9, 2026
CALIFORNIA, United States, Sept. 9, 2026 /PRNewswire/ -- Dryness, rough texture, loss of firmness, and fine lines are common concerns as skin ages. While much of the conversation around aging skin focuses on the face, these visible changes can also affect the arms, hands, legs, and other areas of the body. Renue Blue™ developed its Moisturizing Body Cream to address these concerns and support smoother, more hydrated, and healthier-looking skin.
Understanding how a body care product performs in everyday use can provide valuable insight into the consumer experience. Consumer perception studies allow brands to measure how people perceive changes in their skin over time, helping support product claims with results gathered from real users.
In a recent four-week consumer perception study conducted by Citruslabs, Renue Blue™ Moisturizing Body Cream was evaluated for its perceived effects on skin hydration, smoothness, texture, elasticity, firmness, fine lines, and other visible signs of aging. The study included women between the ages of 30 and 65 with at least one visible sign of aging on the body. By Week 4 of using the product, participants reported several notable results:
- 94% agreed that their skin felt more hydrated.
- 94% agreed that their skin felt smoother to the touch.
- 91% agreed that their skin looked healthier overall.
- 89% agreed that the appearance of fine lines on their skin had improved.
- 83% agreed that their skin felt firmer.
- 81% agreed that their skin felt more elastic and less loose or sagging.
"These findings are incredibly encouraging for our research and development team, as they reinforce our approach to creating science-driven formulations that deliver meaningful, visible results. They also help us understand why so many of our customers continue to come back to Renue Blue." - Bryan Nettles, CEO.
Participants also reported positive experiences beyond the appearance and feel of their skin. By the end of the study, 83% agreed that they felt more confident about the appearance of their skin, while 72% agreed that they felt more positive about their body overall. Additionally, 91% said they would like to continue using Renue Blue™ Moisturizing Body Cream, and the same percentage said they would recommend the product to family and friends.
As consumers look for body care products that address more than basic moisturization, Renue Blue™'s investment in consumer research reflects its commitment to understanding how its products perform in real-world routines. The results provide further insight into how consistent use of Renue Blue™ Moisturizing Body Cream may support the look and feel of aging skin, from hydration and smoothness to firmness and confidence.
For more information about Renue Blue™ and Renue Blue™ Moisturizing Body Cream, visit their website.
About Renue Blue™
At Renue Blue™, innovation meets longevity science. As a subsidiary of Renue By Science™, a global leader in NAD+ precursor supplements, Renue Blue™ brings decades of expertise in cellular vitality, bioavailability, and healthy aging to advanced skincare formulations.
Driven by a mission to help people achieve healthier, more resilient skin, Renue Blue™ collaborates with scientists and clinicians at the forefront of longevity research. Every product is developed with a commitment to scientific integrity, quality, and efficacy, making cutting-edge skincare accessible without compromising performance. Learn more at www.renueblue.com.
About Citruslabs
Citruslabs is a leading contract research organization specializing in accessible research for health, wellness, skincare, and consumer brands. By streamlining participant recruitment, data collection, and rigorous analysis, Citruslabs delivers research that brands can use to support and validate their product claims. Learn more at www.citruslabs.com.
SOURCE Renue By Science
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
Why This Vanguard ETF Is One of the Best
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
United States